144 related articles for article (PubMed ID: 30043122)
21. Provider Misinterpretation, Documentation, and Follow-Up of Definitive Urine Drug Testing Results.
Chua I; Petrides AK; Schiff GD; Ransohoff JR; Kantartjis M; Streid J; Demetriou CA; Melanson SEF
J Gen Intern Med; 2020 Jan; 35(1):283-290. PubMed ID: 31713040
[TBL] [Abstract][Full Text] [Related]
22. Urine Drug Testing Among Patients Prescribed Long-Term Opioid Therapy: Patient and Clinician Factors.
Agnoli AL; Howe R; Magnan E; Jerant A; Colby D; Franks P
J Am Board Fam Med; 2023 Aug; 36(4):537-541. PubMed ID: 37468213
[TBL] [Abstract][Full Text] [Related]
23. Implementing an opioid risk assessment telephone clinic: Outcomes from a pharmacist-led initiative in a large Veterans Health Administration primary care clinic, December 15, 2014-March 31, 2015.
Jacobs SC; Son EK; Tat C; Chiao P; Dulay M; Ludwig A
Subst Abus; 2016; 37(1):15-9. PubMed ID: 26675444
[TBL] [Abstract][Full Text] [Related]
24. Responsible, Safe, and Effective Prescription of Opioids for Chronic Non-Cancer Pain: American Society of Interventional Pain Physicians (ASIPP) Guidelines.
Manchikanti L; Kaye AM; Knezevic NN; McAnally H; Slavin K; Trescot AM; Blank S; Pampati V; Abdi S; Grider JS; Kaye AD; Manchikanti KN; Cordner H; Gharibo CG; Harned ME; Albers SL; Atluri S; Aydin SM; Bakshi S; Barkin RL; Benyamin RM; Boswell MV; Buenaventura RM; Calodney AK; Cedeno DL; Datta S; Deer TR; Fellows B; Galan V; Grami V; Hansen H; Helm Ii S; Justiz R; Koyyalagunta D; Malla Y; Navani A; Nouri KH; Pasupuleti R; Sehgal N; Silverman SM; Simopoulos TT; Singh V; Solanki DR; Staats PS; Vallejo R; Wargo BW; Watanabe A; Hirsch JA
Pain Physician; 2017 Feb; 20(2S):S3-S92. PubMed ID: 28226332
[TBL] [Abstract][Full Text] [Related]
25. Cannabis Legalization Does Not Influence Patient Compliance with Opioid Therapy.
Lo SY; Winston-McPherson GN; Starosta AJ; Sullivan MD; Baird GS; Hoofnagle AN; Greene DN
Am J Med; 2019 Mar; 132(3):347-353. PubMed ID: 30419224
[TBL] [Abstract][Full Text] [Related]
26. Compliance with opioid treatment guidelines for chronic non-cancer pain (CNCP) in primary care at a Veterans Affairs Medical Center (VAMC).
Sekhon R; Aminjavahery N; Davis CN; Roswarski MJ; Robinette C
Pain Med; 2013 Oct; 14(10):1548-56. PubMed ID: 23746149
[TBL] [Abstract][Full Text] [Related]
27. Urine drug testing in chronic pain.
Christo PJ; Manchikanti L; Ruan X; Bottros M; Hansen H; Solanki DR; Jordan AE; Colson J
Pain Physician; 2011; 14(2):123-43. PubMed ID: 21412368
[TBL] [Abstract][Full Text] [Related]
28. Utility and application of urine drug testing in chronic pain management with opioids.
Nafziger AN; Bertino JS
Clin J Pain; 2009 Jan; 25(1):73-9. PubMed ID: 19158549
[TBL] [Abstract][Full Text] [Related]
29. They don't know what they don't know: internal medicine residents' knowledge and confidence in urine drug test interpretation for patients with chronic pain.
Starrels JL; Fox AD; Kunins HV; Cunningham CO
J Gen Intern Med; 2012 Nov; 27(11):1521-7. PubMed ID: 22815062
[TBL] [Abstract][Full Text] [Related]
30. A Survey of ASAM Members' Knowledge, Attitudes, and Practices in Urine Drug Testing.
Kirsh KL; Baxter LE; Rzetelny A; Mazuk M; Passik SD
J Addict Med; 2015; 9(5):399-404. PubMed ID: 26335003
[TBL] [Abstract][Full Text] [Related]
31. Clinician Ordering and Management Patterns of Urine Toxicology Results at a Cancer Center.
Yusufov M; Melanson SEF; Kang P; Kematick B; Schiff GD; Chua IS
J Pain Symptom Manage; 2024 Jul; 68(1):e36-e45. PubMed ID: 38599533
[TBL] [Abstract][Full Text] [Related]
32. Urine Drug Testing in Cancer Pain Management.
Arthur JA
Oncologist; 2020 Feb; 25(2):99-104. PubMed ID: 32043770
[TBL] [Abstract][Full Text] [Related]
33. Frequency, predictors, and outcomes of urine drug testing among patients with advanced cancer on chronic opioid therapy at an outpatient supportive care clinic.
Arthur JA; Edwards T; Lu Z; Reddy S; Hui D; Wu J; Liu D; Williams JL; Bruera E
Cancer; 2016 Dec; 122(23):3732-3739. PubMed ID: 27509305
[TBL] [Abstract][Full Text] [Related]
34. Using urine drug testing to support healthy boundaries in clinical care.
Heit HA; Gourlay DL
J Opioid Manag; 2015; 11(1):7-12. PubMed ID: 25750160
[TBL] [Abstract][Full Text] [Related]
35. Shorter drug testing intervals are associated with improved drug misuse rates.
Gudin J; Mehta N; McClure FL; Niles JK; Kaufman HW
J Opioid Manag; 2020 Sep/Oct 2020; 16(5):357-373. PubMed ID: 33226093
[TBL] [Abstract][Full Text] [Related]
36. Choosing the right laboratory: a review of clinical and forensic toxicology services for urine drug testing in pain management.
Reisfield GM; Goldberger BA; Bertholf RL
J Opioid Manag; 2015; 11(1):37-44. PubMed ID: 25750163
[TBL] [Abstract][Full Text] [Related]
37. Medical cannabis use among patients with chronic pain in an interdisciplinary pain rehabilitation program: Characterization and treatment outcomes.
Shah A; Craner J; Cunningham JL
J Subst Abuse Treat; 2017 Jun; 77():95-100. PubMed ID: 28476279
[TBL] [Abstract][Full Text] [Related]
38. Urine drug testing in pain medicine.
Heit HA; Gourlay DL
J Pain Symptom Manage; 2004 Mar; 27(3):260-7. PubMed ID: 15010104
[TBL] [Abstract][Full Text] [Related]
39. Novel methodology to measure pre-procedure antimicrobial prophylaxis: integrating text searches with structured data from the Veterans Health Administration's electronic medical record.
Mull HJ; Stolzmann K; Kalver E; Shin MH; Schweizer ML; Asundi A; Mehta P; Stanislawski M; Branch-Elliman W
BMC Med Inform Decis Mak; 2020 Jan; 20(1):15. PubMed ID: 32000780
[TBL] [Abstract][Full Text] [Related]
40. Correlates of opiate misuse based on aberrant urine drug tests for patients on chronic opiate therapy in a safety-net, academic primary care clinic.
Bakhai S; Thilagar B; Reynolds JL; Leonard KE
J Opioid Manag; 2018; 14(1):23-33. PubMed ID: 29508893
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
